JPRN-jRCT2080224848已完成3 期
An Extension Study of TS-152 in Subjects with Rheumatoid Arthritis
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 505
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •(1)At visit1(-4 weeks), Subject must be fully informed about the study and must obtain written informed consent from the subject himself.
- •(2)At Visit2(0 week), Subjects must have completed the previous study (TS152-3000-JA or TS152-3001-JA) ,and must have completed all evaluations required at the follow-up visit.
排除标准
- •Subjects who had serious adverse drug reactions in the previous study.
- •At Visit1(-4 weeks) or Visit2 (0 week), Subjects who have not recovered from clinically important adverse events.
研究者
相似试验
已完成
2 期
ate Phase II Study of TS-142 in Patients with InsomniaInsomnia DisorderJPRN-jRCT2080225269Taisho Pharmaceutical Co., Ltd.160
已完成
2 期
Early Phase II Clinical Study of TS-142 in Patients with InsomniaInsomniaJPRN-jRCT2080223515Taisho Pharmaceutical co., LTD32
已完成
3 期
An Extension Study of TS-152 in Subjects With Rheumatoid ArthritisRheumatoid ArthritisNCT04077567Taisho Pharmaceutical Co., Ltd.401
已完成
1 期
A clinical pharmacology study of TS-142 in patients with obstructive sleep apnea hypopnea.Obstructive sleep apnea hypopneaJPRN-jRCT2031200373Mita Seiji40
进行中（未招募）
不适用
A Study of TRU-016 in Combination with Rituximab and Bendamustine in Subjects with Relapsed Slow-Growing Cancer of the Lymph Nodes (Indolent Lymphoma)Relapsed Indolent LymphomaMedDRA version: 14.0Level: HLGTClassification code 10025320Term: Lymphomas non-Hodgkin's B-cellSystem Organ Class: 10005329 - Blood and lymphatic system disordersEUCTR2010-023335-41-ATAbbott88